New Heart Failure Medications 2022- FDA-Approved for Patients with Heart Failure with Reduced Ejection Fraction
In today's day and age, modern medicine is making so much progress with research and development. There are a lot of treatments available for heart failure but still a need to find better medications because of the increasing number of patients with heart failure. This article will give information about the new heart failure medications in 2022 approved by the FDA. Read ahead till the end to learn more about the new medicine in detail.
Table of Contents :
- What is the New Medication for Heart Failure?
- Principal Findings of New Treatment for Heart Failure
- Findings from the trial: Advantages of the New Medications of Heart Failure 2022
- Who can't take this new medication for Heart failure?
Heart failure occurs when your heart becomes weak or stiff and struggles to pump blood and oxygen to the rest of your body. Heart failure can result from a heart attack, excessive blood pressure, coronary artery disease, genetic cardiac abnormalities, heart valve disease and other risk factors.
It is a common disease affecting at least 60 million people worldwide, and the number is growing yearly. Although various treatments are available for the condition, the mortality rates are high and advanced medications are needed to help the patients.
As one of the world's top causes of disability and mortality, with devastating consequences for healthcare systems and the global economy, it is critical to develop and provide solutions to fill the current gaps in heart failure therapy. Millions of lives are at stake if this disease's treatment landscape is improved.
The U.S. Food and Drug Administration (FDA) ensures that safe and effective medications are available to improve patients' health. They understand that there is a need for a new treatment for heart failure. They approved a new medication for heart failure on 24th February 2022, called . It is sold under the brand name Jardiance.
What is the New Medication for Heart Failure?
Jardiance was first introduced in 2014 by the FDA to treat type 2 Diabetes.
Jardiance has also been licensed to lower the risk of cardiovascular death in individuals with type 2 diabetes and pre-existing cardiovascular disease and those with heart failure and a poor ejection fraction.
Jardiance is the first and only heart failure medication to show a statistically significant risk reduction in cardiovascular mortality and heart failure hospitalization, independent of ejection fraction.
The FDA clearance is a big step forward for the nearly 3 million individuals in the United States who have heart failure with maintained ejection fraction, which has been identified as "the single highest unmet need in cardiovascular medicine."
The studies have shown that a randomized, multinational, double-blind trial comparing 2,997 people who received Jardiance, 10m mg once a day, to 2,991 participants who got the placebo assessed the safety and efficacy as an addition to standard of care medication.
Would you like to know how the study was conducted? Here it is..
The patients were randomly assigned to either empagliflozin 10 mg (n = 2,997) or a corresponding placebo (n = 2,991).
Diabetes status, geographic region, estimated glomerular filtration rate (eGFR) and left ventricular ejection fraction (LVEF; 50%/50%) were all used to stratify the trial. All of the patients were getting proper heart failure therapy.
Principal Findings of New Treatment for Heart Failure
The major outcome, cardiovascular (CV) mortality or HF hospitalization, was 13.8% vs. 17.1% for empagliflozin vs. placebo (hazard ratio [HR] 0.79, 95% confidence interval [CI] 0.69-0.90, p 0.001).
CV death: 7.3% vs. 8.2% (HR 0.91, 95% CI 0.76-1.09)
Hospitalization for heart failure: 8.6% vs. 11.8% (HR 0.71, 95% CI 0.60-0.83)
The benefit for the primary outcome was comparable in persons with and without type 2 diabetes. The advantage appeared to be considerably diminished in individuals with an EF of 60%.
"We were participating in the study, and it was amazing to see the findings," says Dr. Sangrigoli, a phase III clinical trial investigator for EMPEROR-Preserved®. “Before this, we had no treatment for those with heart failure who had normal (preserved) cardiac function, which accounted for 50% of our heart failure patients.”
Findings from the trial: Advantages of the New Medications of Heart Failure 2022
"Empagliflozin has demonstrated a statistically significant and clinically relevant effect in patients with heart failure throughout the spectrum of ejection fraction in phase III studies," stated Javed Butler, M.D., chairman of the Department of Medicine at the University of Mississippi.”
Who can't take this new medication for Heart failure?
- Jardiance is not recommended for persons who have type 1 diabetes. It may increase their chances of developing diabetic ketoacidosis (increased ketones in the blood or urine).
- Jardiance is not recommended for people with type 2 diabetes who have the significant renal disease because it may not function.
- You could get severe Urinary Tract Infections due to Jardiance. If you see any UTIs, such as a burning sensation while urinating, frequent urination, pain in the stomach or pelvis area, fever, or chills, you should talk to your doctor about it.
- If you combine Jardiance with another medication that might cause low blood sugar, such as sulfonylurea or insulin, your chance of developing low blood sugar increases.
Not all the side effects of Jardiance are seen in everyone. You should inform your doctor about your medical history before taking Jardiance so that they can make a firm decision about it.
The complexity of heart failure needs that medical professionals think and act holistically, with a patient-centered approach. They should work together to achieve the shared aim of knowing the subtleties of the heart failure patient experience to progress early identification, intervention, and access to novel treatment options that will improve patients' outcomes.
Cost of Heart Treatment in India
Frequently Asked Questions
Question and Answers (109)
List of 25 Best Hospitals in The World 2022In this article, we will discuss the best hospitals in the world based on their facilities and services. Also, will discuss various factors that need to be considered while choosing a hospital for treatment. Here is a list of famous and the best hospitals globally for 2022.
12 Best Heart Surgeons in the World- Updated 2022Heart surgery is one of the most advanced procedures in the world of medicine. It is also one of the riskiest and most complex surgeries a doctor can perform on a patient. In most cases, patients requiring heart surgery have already reached a critical stage where their life is at stake if something isn't done immediately. Hence, it is essential to have a reliable heart surgeon perform the surgery. This article will introduce you to some of the best heart surgeons in the world operating from some of its finest hospitals and clinics. If you know someone who needs this kind of assistance, do share this article with them!
New Treatment for Heart Failure 2022- FDA Approved Treatment for Chronic Heart FailureChronic heart failure is a life-threatening condition. Hence, it is necessary to get effective treatment as soon as possible. There were not many options available for chronic heart failure treatment earlier. But with the approval of Furoscix for Chronic Heart Failure, it may give relief to many patients. This new treatment for chronic heart failure is considered very promising due to several factors. We have discussed everything you need to know about Furoscix. So please read the article carefully!
Stem Cell Therapy For Heart Disease 2022( All You Need To Know)Heart disease is one of the leading causes of disability and death around the world. It is also very difficult to treat, as heart tissue does not repair itself easily. Current treatments only include medication and surgery. They treat the symptoms, but never the actual cause. But now, doctors have discovered a promising new treatment that could accomplish this, making heart transplants a thing of the past. Scroll on to find out about stem cell therapy for heart disease.
New treatment for Coronary Artery Disease- FDA Approved 2022Coronary Heart Disease (CAD) is a severe heart disease. It is a global threat responsible for millions of people's lives. Modern medicine can treat a broad range of people with CAD, yet it's far from perfect. Hence, researchers keep on working to innovate more treatment methods. The Onyx Frontier-DES is one such innovation! This new treatment has unlocked many new possibilities for treating CAD. We have discussed everything you need to know about this new treatment for coronary artery disease. So make sure you read the article to the end!
New Treatment for Hypertrophic Cardiomyopathy 2022- FDA ApprovedoHCM is a rare heart condition that can cause serious symptoms and even death. In 2022, Camzyos made a major breakthrough in oHCM treatment. Mavacamten is the new treatment for hypertrophic cardiomyopathy. It is the world’s first and only FDA-approved allosteric and reversible inhibitor, specifically for patients living with symptomatic obstructive HCM.